These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8059798)

  • 41. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefotaxime optimal dosage in adult patients. A reappraisal.
    Simon A; d'Aubrac CA; Safran C; Carbon C
    Drugs; 1988; 35 Suppl 2():221-30. PubMed ID: 3293977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia.
    Chaudhary M; Ayub SG; Mir MA;
    J Infect Public Health; 2018; 11(5):691-697. PubMed ID: 29803638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
    Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
    Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety profile and efficacy of cefotaxime for the treatment of hospitalized children.
    Jacobs RF; Darville T; Parks JA; Enderlin G
    Clin Infect Dis; 1992 Jan; 14(1):56-65. PubMed ID: 1571464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapeutic effect of ceftizoxime on infection in patients with lung cancer].
    Hiraki S; Ohnoshi T; Tamura M; Kawahara S; Miyamoto H; Nishii K; Kimura I
    Jpn J Antibiot; 1986 Jan; 39(1):87-93. PubMed ID: 3009911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbapenems: monotherapy in intra-abdominal sepsis.
    Wilson SE
    Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of imipenem in severe infections.
    Baumgartner JD; Glauser MP
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():141-8. PubMed ID: 6321426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftizoxime in moderate-to-severe infections.
    Johnson ES; Smith LG
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():151-7. PubMed ID: 6296000
    [No Abstract]   [Full Text] [Related]  

  • 53. Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian tertiary care institution.
    Tin LY; Pitre M; Conly JM
    Diagn Microbiol Infect Dis; 1995; 22(1-2):135-40. PubMed ID: 7587028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective randomized comparative studies of mezlocillin/cefotaxime vs. gentamicin/cefoxitin.
    Kosmidis J; Daikos GK
    J Antimicrob Chemother; 1983 May; 11 Suppl C():91-5. PubMed ID: 6311782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
    Taşkiran B; Colakoğlu O; Sözmen B; Unsal B; Aslan SL; Buyraç Z
    Turk J Gastroenterol; 2004 Mar; 15(1):34-8. PubMed ID: 15264119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.
    Gomis M; Herranz A; Aparicio P; Filloy JL; Pastor J
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():45-52. PubMed ID: 2228844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of ceftizoxime on various infections in patients with underlying diseases].
    Nakatomi M; Sakugawa H; Shimoji K; Kaneshima H; Aragaki T; Urasaki M; Irabu Y; Ogimi T; Makishi K; Kinjo Y
    Jpn J Antibiot; 1984 May; 37(5):817-22. PubMed ID: 6090723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.